未找到相关数据
GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms
被引：5
|作者：
Gomez-Peralta, Fernando
[1
]
Abreu, Cristina
[1
]
Rizzo, Manfredi
[2
]
机构：
[1] Gen Hosp Segovia, Unit Endocrinol & Nutr, Segovia, Spain
[2] Univ Palermo, Sch Med, Promise Dept, Palermo, Italy
关键词：
GLP-1 receptor agonists;
SGLT2;
inhibitors;
Safety;
Clinical practice;
Research;
GLOMERULAR-FILTRATION-RATE;
SEMAGLUTIDE;
OUTCOMES;
D O I：
10.1016/j.jdiacomp.2023.108553
中图分类号：
R5 [内科学];
学科分类号：
1002 ;
100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文